MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Interest Expenses of $2.6 million for Q4 2025, down 14.36% on a QoQ basis from $3.1 million in Q3 2025, and up 50.95% year-over-year from $1.7 million in Q4 2024.
MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Interest Expenses history runs 9 years deep, the most recent figure standing at $2.6 million for Q4 2025.
- Quarterly Interest Expenses rose 50.95% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.5 million (down 9.8% YoY) and the FY2025 annual result came in at $174.8 million, up 17.02% from the prior year.
- Interest Expenses was $2.6 million for Q4 2025 at MeiraGTx Holdings, down from $3.1 million in the prior quarter.
- Across five years, Interest Expenses topped out at $8.6 million in Q1 2025 and bottomed at -$3.4 million in Q4 2021.
- A 5-year average of $2.5 million and a median of $3.0 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses sank 9516.67% — and 2022, when it surged 198.32%.
- MeiraGTx Holdings' Interest Expenses stood at -$3.4 million in 2021, then surged by 198.32% to $3.3 million in 2022, then retreated by 1.59% to $3.3 million in 2023, then tumbled by 46.98% to $1.7 million in 2024, then jumped by 50.95% to $2.6 million in 2025.
- Business Quant data shows MGTX's Interest Expenses at $2.6 million in Q4 2025, $3.1 million in Q3 2025, and $3.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 2.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.63 Mn |
| Dec 31, 2025 | 2.63 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.38 Mn |